Seelos Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

1,211,726

Value ($000)

223

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	223	0.0%	1,211,726	9/30/2023
2023 Q2	8/11/2023	1,394	0.0%	1,166,905	6/30/2023
2023 Q1	5/15/2023	787	0.0%	1,138,001	3/31/2023
2022 Q4	2/13/2023	757	0.0%	1,115,883	12/31/2022
2022 Q3	11/14/2022	1,141	0.0%	1,107,829	9/30/2022
2022 Q2	8/12/2022	681	0.0%	1,001,597	6/30/2022
2022 Q1	5/13/2022	1,355	0.0%	1,617,707	3/31/2022
2021 Q4	2/11/2022	2,583	0.0%	1,584,988	12/31/2021
2021 Q3	11/12/2021	4,149	0.0%	1,721,677	9/30/2021
2021 Q2	8/13/2021	3,592	0.0%	1,360,649	6/30/2021
2021 Q1	5/12/2021	2,709	0.0%	542,954	3/31/2021
2020 Q4	2/12/2021	492	0.0%	311,618	12/31/2020
2020 Q3	11/13/2020	144	0.0%	154,397	9/30/2020
2020 Q2	8/13/2020	155	0.0%	154,397	6/30/2020
2020 Q1	5/14/2020	75	0.0%	154,397	3/31/2020
2019 Q4	2/13/2020	206	0.0%	154,397	12/31/2019